Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies, Rheumatology, vol.51, issue.6, pp.1017-1043, 2012. ,
DOI : 10.1093/rheumatology/ker269
Scleroderma, New England Journal of Medicine, vol.360, issue.19, pp.1989-2003, 2009. ,
DOI : 10.1056/NEJMra0806188
Preclinical and translational research to discover potentially effective antifibrotic therapies in systemic sclerosis, Current Opinion in Rheumatology, vol.25, issue.6, pp.679-85, 2013. ,
DOI : 10.1097/01.bor.0000434598.51526.0e
Experimental models of dermal fibrosis and systemic sclerosis, Joint Bone Spine, vol.80, issue.1, pp.23-31, 2013. ,
DOI : 10.1016/j.jbspin.2012.06.005
The Nuclear Receptor Constitutive Androstane Receptor/NR1I3 Enhances the Profibrotic Effects of Transforming Growth Factor ?? and Contributes to the Development of Experimental Dermal Fibrosis, Arthritis & Rheumatology, vol.44, issue.11, pp.3140-50, 2014. ,
DOI : 10.1002/art.38819
Animal models of systemic sclerosis: Prospects and limitations, Arthritis & Rheumatism, vol.47, issue.Suppl 5, pp.2831-2875, 2010. ,
DOI : 10.1002/art.27647
Animal model of systemic sclerosis, The Journal of Dermatology, vol.125, issue.1, pp.26-41, 2010. ,
DOI : 10.1111/j.1346-8138.2009.00764.x
Induction of Autoimmunity in a Bleomycin-Induced Murine Model of Experimental Systemic Sclerosis: An Important Role for CD4+ T Cells, Journal of Investigative Dermatology, vol.129, issue.7, pp.1688-95, 2009. ,
DOI : 10.1038/jid.2008.431
Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking Scleroderma, Journal of Investigative Dermatology, vol.112, issue.4, pp.456-62, 1999. ,
DOI : 10.1046/j.1523-1747.1999.00528.x
Early growth response 3 (Egr-3) is induced by transforming growth factor-beta and regulates fibrogenic responses ,
Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis, Annals of the Rheumatic Diseases, vol.72, issue.6, pp.1089-98, 2013. ,
DOI : 10.1136/annrheumdis-2012-201759
Vinculin???actin interaction couples actin retrograde flow to focal adhesions, but is dispensable for focal adhesion growth, The Journal of Cell Biology, vol.111, issue.1, pp.163-77, 2013. ,
DOI : 10.1038/ncb1765
Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains, Archives of Dermatological Research, vol.292, issue.11, pp.535-576, 2000. ,
DOI : 10.1007/s004030000183
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study, Annals of the Rheumatic Diseases, vol.43, issue.(Suppl 3), pp.1-7, 2014. ,
DOI : 10.1136/annrheumdis-2014-206386
2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats, Vascular Pharmacology, vol.51, issue.2-3, pp.190-197, 2009. ,
DOI : 10.1016/j.vph.2009.06.002
Modulation of autoimmune rheumatic diseases by oestrogen and progesterone, Nature Reviews Rheumatology, vol.146, issue.12, pp.740-51, 2014. ,
DOI : 10.4049/jimmunol.164.12.6237
Animal Model of Sclerotic Skin. IV: Induction of Dermal Sclerosis by Bleomycin is T Cell Independent, Journal of Investigative Dermatology, vol.117, issue.4, pp.999-1001, 2001. ,
DOI : 10.1046/j.0022-202x.2001.01509.x
Bleomycin and the skin, British Journal of Dermatology, vol.87, issue.5, pp.869-75, 2006. ,
DOI : 10.1111/j.1600-0749.1991.tb00446.x
Transforming growth factor ?????at the centre of systemic sclerosis, Nature Reviews Rheumatology, vol.50, issue.12, pp.706-725, 2014. ,
DOI : 10.1164/rccm.201011-1874OC